Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Frontline Targeted Therapies Plus R-CHOP Boosts PFS in High-Risk B-Cell Lymphomas

Frontline Targeted Therapies Plus R-CHOP Boosts PFS in High-Risk B-Cell Lymphomas
ShareXFacebook

(MedPage Today) -- CHICAGO -- Combining two targeted therapies with standard-of-care chemotherapy extended progression-free survival (PFS) in patients with newly diagnosed B-cell lymphomas, according to data from the frontMIND trial. In the...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

You Can't Blame a Payer for Trying
MedPage Today

You Can't Blame a Payer for Trying

(MedPage Today) -- I have spent 20 years working in out-of-network healthcare reimbursement. After reading the New York Times article "A $440,000 Breast Reduction? How Doctors Cash In on a Health Care Law," I felt the payer's use of the independent...

Read more →
Advertisement